City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
July 12, 2017 | Samantha Bonar
Monica Curiel was 19 years old, a freshman in college, when diagnosed. Now a survivor, her book, Stella's Picture Day, for pediatric cancer patients, was published in May 2016.
July 7, 2017 | Samantha Bonar
Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects in childhood cancer survivors from bilingual and Spanish-speaking families.
June 29, 2017 | Katie Neith
Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.
June 14, 2017 | Abe Rosenberg
Suzette Hodnett is a Stage 4 cancer survivor who captivated every medical professional who operated on her, medicated her, irradiated her or rehabbed her. She is also the author of "The Journey is Everything: Saying Yes to Cancer."
June 5, 2017 | Michael Easterling
As an oncology nurse, Christine Magnus Moore, R.N., B.S.N., has cared for patients going through the most challenging circumstances one can imagine. But she didn’t fully comprehend the courage of these cancer patients until she became one herself.
May 26, 2017 | Samantha Bonar
Four years ago, Mark Paolera, now 39, was busy enjoying the typical active California lifestyle, including mountain biking, hiking and deep-sea fishing. After a battery of tests, Paolera was diagnosed with Stage 2 Hodgkin lymphoma in May of 2014.
February 9, 2017 | Michael Easterling
Deana and Steve Campbell made a generous donation to City of Hope to establish The Deana and Steve Campbell Chief Clinical Officer’s Distinguished Chair in Honor of Alexandra Levine, M.D. The holder of the endowed Chair, yet to be recruited, will demonstrate the same level of commitment to City of Hope’s values, ideals and philosophy as Levine has personified.
February 1, 2017 | Letisia Marquez
Alex F. Herrera, M.D., an assistant professor in City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation, and a team of doctors at City of Hope and the Dana-Farber Cancer Institute examined how well patients whose double-hit and/or double-expressor lymphoma had recurred, or was resistant to initial treatment, fared after they had received high-dose chemotherapy and underwent an autologous stem cell transplantation.
January 9, 2017 | Abe Rosenberg
Everything changed when Hodgkin lymphoma patient Lowell Winer joined a Phase II clinical trial examining the effectiveness of brentuximab vedotin (BV) after a failed transplant. The BV worked immediately, achieving a complete remission which, year after year, proved to be durable beyond anyone's expectations.